Ikure Techsoft Private Limited - Due diligence report
A 360° intelligence report on Ikure: trust score, financial health, credit view, compliance, directors, growth and distress signals - genera…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Ikure — 360° Intelligence Report
Generated from MCA filings & public recordsIkure is assessed as Moderate with a Trust Score of 70/100. Ikure is an active private limited indian non-government company incorporated in 2010, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 29 Jun 2026 from the latest processed filings. Ikure Techsoft Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
Charges position: 2 open (1.20 cr) · 0 satisfied (-).
| Lender | Charges | Amount |
|---|---|---|
| Axis Bank Limited | 1 | 48.0 cr |
| The Hongkong And Shanghai Banking Corporation Limited | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2023 - filings overdue.
- Litigation present in 1 court forum(s).
- 1 active GST registration(s).
Director Intelligence
Stability score: 35/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SUJAY RANJAN SANTRA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SARAH SANTRA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- SUJAY RANJAN SANTRA has DIN status "Disqualified by RoC u/s 164(2)".
- 4 director exits in 3 years - high churn.
- Average tenure above 5 years.
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
Ownership & Group Intelligence
As per FY 2022 annual returnPromoters hold a majority stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 80 · Distress 80Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 1.20 cr already registered.
- Compliance gaps should be priced into terms.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Sripath Diagnostics Private Limited | U93030TG2014PTC092566 | Hyderabad, Telangana, India |
| Radon Oncology Private Limited | U85100KA2012PTC065541 | Hubli, Karnataka, India |
| Evron Biocraft Private Limited | U74999MH2014PTC255399 | Mumbai, Maharashtra, India |
| Xeina Drugs Private Limited | U92100UP2017PTC159725 | Noida, Uttar Pradesh, India |
| L7H Life Resources Private Limited | U85110KA2012PTC065395 | Bangalore, Karnataka, India |
| R K Life Services Private Limited | U85110AS2002PTC006987 | Guwahati, Assam, India |
| Meddo Health | U85100HR2018PTC076187 | Gurgaon, Haryana, India |
| Sankeerthana Hospitals Private Limited | U85110KA2016PTC087020 | Bangalore, Karnataka, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Ikure before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Ikure: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Ikure - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Ikure pays its suppliers before you extend credit terms.
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Ikure - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Ikure an active company?
Ikure has MCA status “Active” with a compliance score of 68/100 (Moderate).
Is Ikure financially healthy?
Ikure has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Ikure?
Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Ikure?
Promoters hold a majority stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Ikure have loans or charges against its assets?
2 open charge(s) are registered against its assets.
Is Ikure up to date with its ROC filings?
Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 68/100 (Moderate).
Is it risky to lend to Ikure?
Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.